OpenBilldrug price receipt

NADAC week of 2026-10-14

OSELTAMIVIR 6 MG/ML SUSPENSION

For 60 mL

Pharmacies pay

$8.98 filed

60 × $0.14964 per ML

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23, 2026-09-30 · as of 2026-10-14 · retrieved 2026-10-17

Medicare

We don’t know yet

No Medicare reference price. Part D: OpenBill did not match this NDC to a usable Medicare Part D spending row. Either Part D has none for it, or the rows that share its name could not safely be tied to it (for example, they mix units, routes or release forms, or the drug is sold over the counter, which Part D does not cover). Part B: This NDC is not in the current quarter’s Medicare Part B NDC-HCPCS crosswalk, so it has no Part B payment limit.


The spread

We don’t know yet

There is no Medicare figure to compare with, so there is no spread.

Cost-plus estimate

$15.33 estimated

$8.98 + $1.35 (15%) + $5.00 fee per fill = $15.33

This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23, 2026-09-30 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

OSELTAMIVIR 6 MG/ML SUSPENSION is how the CMS NADAC file names this product. The FDA NDC Directory lists it as oseltamivir phosphate, under the trade name “Oseltamivir Phosphate for Oral Suspension”.

FDA gives its dosage form as “powder, for suspension”, “suspension” and “for suspension” and its route as oral.

FDA lists 11 labelers (the companies named on the label) for its NDCs, among them Teva Pharmaceuticals USA, Inc., Lannett Company, Inc. and Ajanta Pharma USA Inc.

FDA’s Established Pharmacologic Class for it is Neuraminidase Inhibitor.

The NADAC file of 2026-10-14 prices it under 11 NDCs (National Drug Codes).

NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $8.98 for 60 mL (60 × $0.14964 per ML, rounded to the cent), by the CMS NADAC file of 2026-10-14; those prices took effect between 2026-09-23 and 2026-09-30. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation codes for it: 1, calculated from the most recently completed pharmacy survey; 5, calculated based on package size.

The 11 labelers

LabelerNDCsPharmacies pay per unit
Ajanta Pharma USA Inc.1$0.14964 per ML filed
Alvogen Inc.1$0.14964 per ML filed
Amneal Pharmaceuticals NY LLC1$0.14964 per ML filed
Aurobindo Pharma Limited1$0.14964 per ML filed
Exelan Pharmaceuticals, Inc.1$0.14964 per ML filed
Lannett Company, Inc.1$0.14964 per ML filed
Lupin Pharmaceuticals, Inc.1$0.14964 per ML filed
Novadoz Pharmaceuticals LLC1$0.14964 per ML filed
Oryza Pharmaceuticals Inc.1$0.14964 per ML filed
Teva Pharmaceuticals USA, Inc.1$0.14964 per ML filed
Zydus Pharmaceuticals USA Inc.1$0.14964 per ML filed

When these prices took effect

All 11 NDCs, with labeler and price
  • 00093-8180-64 · Teva Pharmaceuticals USA, Inc. · $0.14964 per ML · eff. 2026-09-23 filed
  • 00527-5137-62 · Lannett Company, Inc. · $0.14964 per ML · eff. 2026-09-23 filed
  • 27241-0139-09 · Ajanta Pharma USA Inc. · $0.14964 per ML · eff. 2026-09-23 filed
  • 47781-0384-26 · Alvogen Inc. · $0.14964 per ML · eff. 2026-09-23 filed
  • 59651-0597-60 · Aurobindo Pharma Limited · $0.14964 per ML · eff. 2026-09-23 filed
  • 68180-0678-01 · Lupin Pharmaceuticals, Inc. · $0.14964 per ML · eff. 2026-09-23 filed
  • 69238-1273-06 · Amneal Pharmaceuticals NY LLC · $0.14964 per ML · eff. 2026-09-23 filed
  • 70710-1165-06 · Zydus Pharmaceuticals USA Inc. · $0.14964 per ML · eff. 2026-09-23 filed
  • 72205-0060-78 · Novadoz Pharmaceuticals LLC · $0.14964 per ML · eff. 2026-09-23 filed
  • 72516-0029-01 · Oryza Pharmaceuticals Inc. · $0.14964 per ML · eff. 2026-09-30 filed
  • 76282-0739-52 · Exelan Pharmaceuticals, Inc. · $0.14964 per ML · eff. 2026-09-23 filed

Other strengths, forms and brands

5 other products in the NADAC file share the FDA nonproprietary name oseltamivir phosphate with OSELTAMIVIR 6 MG/ML SUSPENSION.

ProductPharmacies pay per unitMedicare per unit
OSELTAMIVIR 6 MG/ML SUSPENSION this page
generic · powder, for suspension / suspension / for suspension
$0.14964 per ML filed
eff. 2026-09-23 to 2026-09-30
We don’t know yet
OSELTAMIVIR PHOS 30 MG CAPSULE
generic · capsule
$0.67955 per EA filed
eff. 2026-09-23
We don’t know yet
OSELTAMIVIR PHOS 45 MG CAPSULE
generic · capsule
$0.7872 per EA filed
eff. 2026-09-23
We don’t know yet
OSELTAMIVIR PHOS 75 MG CAPSULE
generic · capsule
$0.79621 per EA filed
eff. 2026-09-23
We don’t know yet
TAMIFLU 6 MG/ML SUSPENSION
brand · powder, for suspension
$2.43293 per ML filed
eff. 2026-02-18
We don’t know yet
TAMIFLU 75 MG CAPSULE
brand · capsule
$14.51856 per EA filed
eff. 2026-03-18
We don’t know yet

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. between 2026-02-18 and 2026-09-30 (4 dates) · as of 2026-10-14 · retrieved 2026-10-17

What Medicare paid

We don’t know yet; the card above says why.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

Questions

Why does this page start at 60 mL?
NADAC prices this product per ML. The FDA NDC Directory’s package description gives 60 mL in one package for all 11 NDCs of this product (“1 BOTTLE in 1 CARTON (0093-8180-64) / 60 mL in 1 BOTTLE”), so the card starts at one package: 60 ML. Change it to match your prescription.